Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-31.36%
↑ 88% vs avg
Percentile
P44
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-260.79%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -31.36% | +96.4% |
| 2024 | -870.98% | +28.2% |
| 2023 | -1213.84% | -407.6% |
| 2022 | -239.12% | +5.3% |
| 2021 | -252.61% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |